The collaborative project is partnered with CQDM, Simon Fraser University, Amgen, Merck, and Servier.
Category: Press Release
GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada
The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy
GlycoNet-affiliated start-up 48Hour Discovery and Merck initiate drug discovery project
Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform
New glycomics research investments from GlycoNet to facilitate a resilient recovery for Canada
$1.3 million in funding to support new sugar research to tackle unmet needs in national healthcare
GlycoNet start-up PanTHERA CryoSolutions receives up to $4 million investment to advance technologies in regenerative medicine
The made-in-Canada technology is revolutionizing the cryopreservation of cell and tissues.
GlycoNet scientists exploring connection between glycans in blood group and COVID-19
Pediatric cardiologist Lori West is one of six researchers from the University of Alberta receiving $2.8 million in federal funding for “exceptional opportunities” in fight against the pandemic.
GlycoNet Investigator’s new process fast-tracks drug treatments for viral infections and cancer
Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from GlycoNet Investigator Dr. Robert Britton at Simon Fraser University and his international team.
PlantForm partners with GlycoNet’s Associate Scientific Director for a more effective COVID-19 serology test
The partnership, funded by NSERC Alliance Grant, will support Dr. Warren Wakarchuk’s work on the role of O-glycans in triggering immune response.
Canadian Glycomics Network investing $3.9 million in collaborative projects to address research gaps in Canadian healthcare
The fund aims to support projects that mitigate the impact of healthcare burden in Canada and contribute to better understanding of challenging diseases.
English 
French